Insiders · Profile

Downs Christopher

Chief Financial Officer at CNS Pharmaceuticals · CFO (interim) at InfuSystem. Filing since 14 Aug 2017. CIK 0001705978

Company
Date
Role
Action
Shares
Amount
Of holding
1 Feb 2024
Chief Financial Officer
Bought
66,666
$20.00K
181%
22 Aug 2023
Chief Financial Officer
Bought
27,000
$34.18K
276%
17 Apr 2023
Chief Financial Officer
Bought
3,100
$9.92K
50.4%
6 Dec 2021
Chief Financial Officer
Bought
5,000
$4.70K
3.4%
19 Nov 2021
Chief Financial Officer
Bought
4,500
$5.19K
3.2%
24 Aug 2020
Chief Financial Officer
Bought
142,000
$289.68K
opened
14 Aug 2017
CFO (interim)
Bought
7,900
$15.01K
37.7%
7 decisions on file.